| 08/12/2026 7:09 AM | Latigo Biotherapeutics, Inc. (2056611) Issuer Sanofi (1121404) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 08/12/2026 7:18 AM | Latigo Biotherapeutics, Inc. (2056611) Issuer Sanofi (1121404) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/07/2026 2:45 PM | Attovia Therapeutics, Inc. (2058707) Issuer Sanofi (1121404) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/06/2026 5:02 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/30/2026 6:34 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/30/2026 5:28 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/22/2026 8:50 AM | Amundi (1330387) Filed by Sanofi (1121404) Subject | Form SCHEDULE 13G/A | |
| 07/17/2026 5:02 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/07/2026 8:02 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/30/2026 12:27 PM | Sanofi (1121404) Filer | Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
| 06/30/2026 11:54 AM | Sanofi (1121404) Filer | Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
Get the Latest News and Ratings for SNYNF and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Sanofi and its competitors with MarketBeat's FREE daily newsletter.
|
| 06/30/2026 10:45 AM | Sanofi (1121404) Filer | Form NT 11-K | |
| 06/30/2026 10:49 AM | Sanofi (1121404) Filer | Form NT 11-K | |
| 06/24/2026 7:43 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/22/2026 7:43 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/12/2026 10:41 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/08/2026 5:06 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/28/2026 5:06 AM | Sanofi (1121404) Filer | Form SD Specialized Disclosure Report | |
| 05/27/2026 9:31 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/07/2026 7:47 AM | Sanofi (1121404) Filer | Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
| 05/06/2026 5:00 AM | Agomab Therapeutics NV (2020932) Subject Sanofi (1121404) Filed by | Form SCHEDULE 13G | |
| 05/05/2026 5:06 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/29/2026 5:04 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/27/2026 11:58 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/23/2026 6:20 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/15/2026 5:57 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/10/2026 8:58 AM | Amundi (1330387) Filed by Sanofi (1121404) Subject | Form SCHEDULE 13G/A | |
| 03/31/2026 11:19 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/24/2026 10:57 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/10/2026 9:40 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/04/2026 11:26 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/03/2026 5:15 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/23/2026 8:19 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/17/2026 12:28 PM | Sanofi (1121404) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 02/17/2026 11:34 AM | Sanofi (1121404) Filer | Form 20-F Registration statement / Annual report / Transition report | |
| 02/17/2026 11:44 AM | Sanofi (1121404) Filer | Form IRANNOTICE | |
| 02/17/2026 8:33 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/12/2026 8:17 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/11/2026 7:47 AM | Sanofi (1121404) Filer | Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
| 02/10/2026 8:18 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/10/2026 5:06 AM | DYNAVAX TECHNOLOGIES CORP (1029142) Subject Sanofi (1121404) Filed by | Form SC TO-T/A | |
My top 3 AI picks for the next decade (Ad) Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005.
Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade. Click here to get all three AI stock names from Alexander Green |
| 02/06/2026 9:09 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/05/2026 5:17 AM | Sanofi (1121404) Filer | Form S-8 POS | |
| 01/30/2026 6:55 AM | DYNAVAX TECHNOLOGIES CORP (1029142) Subject Sanofi (1121404) Filed by | Form SC TO-T/A | |
| 01/29/2026 7:56 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/28/2026 5:37 AM | DYNAVAX TECHNOLOGIES CORP (1029142) Subject Sanofi (1121404) Filed by | Form SC TO-T/A | |
| 01/23/2026 8:58 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/16/2026 5:02 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/12/2026 5:11 AM | DYNAVAX TECHNOLOGIES CORP (1029142) Subject Sanofi (1121404) Filed by | Form SC TO-T | |
| 01/09/2026 5:09 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/29/2025 3:42 PM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/29/2025 3:44 PM | DYNAVAX TECHNOLOGIES CORP (1029142) Subject Sanofi (1121404) Filed by | Form SC TO-C | |
| 12/29/2025 5:22 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/29/2025 5:23 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/23/2025 8:52 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/22/2025 11:25 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/15/2025 9:17 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/12/2025 11:26 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/03/2025 10:30 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/18/2025 11:29 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/14/2025 4:34 PM | Amundi (1330387) Filed by Sanofi (1121404) Subject | Form SCHEDULE 13G/A | |
| 11/04/2025 9:51 AM | Sanofi (1121404) Filer | Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
| 11/03/2025 10:40 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/31/2025 12:48 PM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/29/2025 10:15 AM | Sanofi (1121404) Filer | Form 424B5 | |
| 10/28/2025 9:57 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/27/2025 8:12 PM | Sanofi (1121404) Subject | Form FWP | |
| 10/27/2025 8:13 PM | Sanofi (1121404) Subject | Form FWP | |
| 10/27/2025 8:15 PM | Sanofi (1121404) Subject | Form FWP | |
| 10/27/2025 8:17 PM | Sanofi (1121404) Subject | Form FWP | |
| 10/27/2025 8:20 PM | Sanofi (1121404) Subject | Form FWP | |
| 10/27/2025 7:32 AM | Sanofi (1121404) Filer | Form 424B5 | |
| 10/27/2025 6:56 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/24/2025 5:20 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/24/2025 5:03 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/15/2025 11:07 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/26/2025 8:41 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/22/2025 1:59 PM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/17/2025 11:03 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/04/2025 11:55 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/03/2025 11:44 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/29/2025 9:36 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |